Open Access

Antiplatelet agents and DOACs in primary and secondary prevention.

Seminar Presentation

2 more presentations in this session

Management of dyslipidaemia.

Speaker: Professor H. Drexel (Feldkirch, AT)

Thumbnail

Diabetes, obesity, uric acid.

Speaker: Professor G. Derumeaux (Creteil, FR)

Thumbnail

Access the full session

Session 8: Primary and Secondary Prevention in Women - Lipid Lowering Agents, Anti-Diabetic Drugs - Antiplatelet Therapy and Anticoagulation

Speakers: Professor H. Drexel, Professor G. Derumeaux
Thumbnail

About the event

Image

Cardiovascular Pharmacotherapy in Women 2022

17 February - 18 February 2022

Related content

Open Access

Round table discussion with audience Q&A, Summary and close.

27 August 2021

Open Access

What should we do when we are presented with an individual who has CVD and comorbid obesity?

27 August 2021

Open Access

What treatment options can cardiologists offer people with CVD and obesity?

27 August 2021

ESC 365 is supported by

logo Novo Nordisk